Volume : 11, Issue : 01, January – 2024
Title:
A SURVEY ON THE INCIDENCE AND SEVERITY OF HYPOGLYCEMIA IN TYPE II DIABETIC PATIENTS USING ORAL ANTI DIABETIC MEDICATIONS
Authors :
Ananth Lakshmi G, Afifa khan, Srija B, Niharika T, Pragathi Reddy D, Deepika A
Abstract :
Hypoglycemia is a condition caused by very low level of sugar (glucose) which is the main energy source of the body. Hypoglycemia is often related to treatment of diabetes. However, a variety of conditions may cause low blood sugar level in people without diabetes like fever, Hypoglycemia is not a disease itself, it’s an indicator of health problem. A survey on incidence and severity of hypoglycemia in a tertiary care Centre with administration of a questionnaire a prospective study was conducted in Apollo Hospitals, Jubilee Hills, Hyderabad. Outpatients enrolled in the study were fully informed and gave their consent. Information was gathered regarding patient demographics, location, risk factors, co-morbid conditions, treatment, ADR, episodes of hypoglycemia. A total of 270 patients were enrolled for the study among which 55% were males and 45% were females. Hypoglycemia was seen in (6%) of the study population. The study results suggested that hypoglycemic incidence was higher in the age groups of 42-67 years (38%). Co-morbid conditions were seen in (52.9%) of the study population which included, HTN, CKD, Thyroid (6.7%), and renal failure (3.3%). The study concludes that the most common reasons of hypoglycemia were altered food habits and the drugs. Sulphonylureas are the drugs involved majorly in the hypoglycemic episodes.
Key words: Hypoglycaemia, Incidence, Tertiary care
Cite This Article:
Please cite this article in press Anantha Lakshmi G et al., A Survey On The Incidence And Severity Of Hypoglycemia In Type Ii Diabetic Patients Using Oral Anti Diabetic Medications., Indo Am. J. P. Sci, 2024; 11 (01).
Number of Downloads : 10
References:
1. Holstein A, Plaschke A. and Egberts, E. (2001), Lower incidence of severe hypoglycemia in patients with type 2 diabetes treated with glimepiride versus glibenclamide. Diabetes Metab Res Rev. 2001 Nov-Dec;17(6):467-73.
2. Suellen M. Curkendall, Bin Zhang, Kelly S. Oh, Setareh A. Williams, Michael and John Graham,et al. study on Incidence and Cost of Hypoglycemia Among Patients with Type II Diabetes in the United States: Analysis of a Health Insurance Database Vol. 18, No. 10 October 2011 pg no. 455- 462.
3. Masato Odawara, Takashi Kadowaki and Yusuke Naito Incidence and predictors of hypoglycemia in Japanese patients with type II diabetes treated by insulin glargine and oral antidiabetic drugs in real-life: ALOHA post-marketing surveillance study sub-analysis. Diabetol Metabolic Syndrome. 2014; 6: 20.
4. Krobot KJ, Ferrante SA, Davies MJ and Seck T, et al.Lower risk of hypoglycemia with sitagliptin compared to glipizide when either is added to metformin therapy: a pre-specified analysis adjusting for the most recently measured HbA(1c) value. Curr Med Res Opin. 2012 August;28(8):1281-1287.
5. Shorr RI, Ray WA, Daugherty JR, Griffin MR. Individual sulfonylureas and serious hypoglycemia in older people. Journal of American Geriatric Society.1996 July; 44(7):751-755.
6. Edridge CL, Dunkley AJ, Bodicoat DH, and Rose TC, et al. Prevalence and Incidence of Hypoglycaemia in 532,542 People with Type 2 Diabetes on Oral Therapies and Insulin: A Systematic Review and Meta-Analysis of Population Based Studies. PLoS One. 2015 June 10;10(6):e0126427.
7. Asplund K, Wiholm BE, Lithner F. Glibenclamide-associated hypoglycaemia: a report on 57 cases. Diabetologia. 1983 June;24(6):412-417.